Prolactinoma
NEJM 349:2035-2041, Schlechte,J.A., 2003
Withdrawal of Long-Term Cabergoline Therapy for Tumoral and Nontumoral Hyperprolactinemia
NEJM 349:2023-2033, Colao,A.,et al, 2003
Management of Pituitary Tumors
Ann Int Med 129:472-483, Shimon,I.&Melmed,S., 1998
Diagnosis and Management of Pituitary Tumours
BMJ 308:1087-1091, Levy,A.&Lightman,S.L., 1994
Clinicopath Conf
Primary Malignant Lymphoma of CNS, Diffuse, Large-Cell]B-Cell Type, Case 36-1994, NEJM 331:861-8684., , 1994
Relapse of Hyperprolactinemia Revisited
NEJM 329:1357, Serri,O.,et al, 1993
Prolactin-Secreting Macroadenomas in Adolescents, Response to Bromocriptine Therapy
Am J Dis Child 147:1057-1061, Tyson,D.,et al, 1993
Diagnosis and Management of Hormone-Secreting Pituitary Adenomas
NEJM 324:822-831, Klibanski,A.&Zervas,N.T., 1991
Treatment of Prolactin-Secreting Pituitary Macroadenomas with the Long-Acting Non-Ergot Dopamine Agonist CV 205-502
Ann Int Med 112:668-673, Vance,M.L.,et al, 1990
Acromegaly in an Infant
Pediatrics 83:998-1002, Blumberg,D.L.,et al, 1989
Hyperprolactinaemia, Common and Treatable
BMJ 297:701-702, Hartog,M.&Hull,M.G.R., 1988
Giant Invasive Prolactinomas
Am J Med 83:995-1002, Murphy,F.Y.,et al, 1987
Primary Radiotherapy of Prolactinomas, Eight-to 15-Year Follow-Up
Am J Med 83:49-58, Mehta,A.E.,et al, 1987
Prolactinomas
Editorial, BMJ 290:182-1841985., Grossman,A.,et al, 1985
Rapid Size Reduction of Giant Prolactinoma Following Medical Treatment
J Comput Assist Tomogr 8:131-133, Perani,D.,et al, 1984
Long-Term Follow-Up of Transphenoidal Selective Adenomectomy for Prolactinoma
JAMA 252:921-924, Rodman,E.F.,et al, 1984
Effect of Dopamine Agonist Withdrawal After Long-Term Therapy in Prolactinomas
Lancet 2:187-192, Johnston,D.G.,et al, 1984
Pergolide for the Treatment of Pituitary Tumors Secreting Prolactin or Growth Hormone
NEJM 309:704-709, Kleinberg,D.K.,et al, 1983
Bromocriptine Reduces Pituitary Tumor Size & Hyper-secretion
JAMA 247:311-316, Spark,R.F.,et al, 1982
CSF Rhinorrhea After Bromocriptine For Prolactinoma
NEJM 306:178, Baskin,D.S.,et al, 1982
Bromocriptine in Management of Large Pituitary Tumours
BMJ 284:1908-1911, Wass,J.A.H.,et al, 1982
Reduction in Size of Prolactin-secreting Tumours in Men Treated with Pergolide
BMJ 285:465-467, Kendall-Taylor,P.,et al, 1982
Regression of Pituitary Prolactinoma With Bromocriptine Administration
JAMA 245:1149-1150, Velentzas,C.,et al, 1981
Prolactinoma:A Question of Rational Treatment
BMJ 283:1561-1562, Edwards,C.R.W.,et al, 1981
Management of Hormone-Secreting Pituitary Adenomas
NEJM 302:210-214, Zervas,N.T.,et al, 1980
Reduction in Size of a Pituitary Tumor by Bromocriptine Therapy
NEJM 300:291-293, McGregor,A.M.,et al, 1979
The Prolactinoma Problem
NEJM 300:313-315, Reichlin,S., 1979
Effect of Bromocriptine on Pituitary Tumor Size
BMJ 2:700-703, McGregor,A.M.,et al, 1979
Galactorrhea:A Study of 235 Cases, Including 48 with Pituitary Tumors
NEJM 296:589, Kleinberg,D.L.,et al, 1977
Galactorrhea, Amenorrhea, & Hyperprolactinemia as Manifestations of Parasellar Meningioma
Arch Int Med 140:1608-1612, Shah,R.P.,et al, 1980
A Young Woman With Hypertonia, Severe Scoliosis, and Encephalopathy
JAMA Neurol 81:83-84, Hua,L.,et al, 2024
Prolactinomas
NEJM 362:1219-1226, Klibanski,A., 2010
Sarcoidosis: Clinical, Hormonal, and Magnetic Resonance Imaging (MRI) Manifestations of Hypothalamic-Pituitary Disease in 9 Patients and Review of the Literature
Medicine 86:259-268, Bihan,H.,et al, 2007
Clinicopath Conf., Prolactinoma
NEJM 347:1604-1611, Case 35-2002, 2002
Acromegaly:Clinical and Biochemical Features in 500 Patients
Medicine 73:233-240, Ezzat,S.,et al, 1994
Hypothalamic-Pituitary Dysfunction after Radiation for Brain Tumors
NEJM 328:87-94, Constine,L.S.,et al, 1993
Pituitary Adenoma in McCune-Albright Syndrome:MR Demonstration
J Comput Assist Tomogr 13:685-688, O'Laughlin,R.L.,et al, 1989
Hyperprolactinaemia:When Is a Prolactinoma Not a Prolactinoma? Editorial
Lancet 2:1002-1004, , 1987
Development of Pituitary Adenoma in Women with Hyper-prolactinaemia
BMJ 288:515-518, Pontiroli,A.E.,et al, 1984
Treatment of Prolactinomas with Megavoltage Radiotherapy
BMJ 288:1105-1109, Grossman,A.,et al, 1984
Recurrence of Hyperprolactinemia after Selective Trans-sphenoidal Adenomectomy in Women with Prolactinoma
NEJM 309:280-283, Serri,O.,et al, 1983
CT Abnormalities of the Pituitary in Hyperprolactinaemic Women with Normal or Equivocal Sellae Radiologically
BMJ 285:1078-1081, Jung,R.T.,et al, 1982
Microadenomas Of The Pituitary & Abnormal Sellar Tomograms In An Unselected Autopsy Series
NEJM 304:156-158, Burrow,G.N.,et al, 1981
Plasma Cell Dyscrasia with Polyneuropathy, Organomegaly, Endocrinopathy, M Protein, & Skin Changes:The POEMS Syndrome
Medicine 59:311-322, Bardwick,P.A., 1980
Prolactin-Secreting Pituitary Adenomas, III. Frequency & Diagnosis in Amenorrhea-Galactorrhea
JAMA 244:1329-1332, Keye,W.R.,et al, 1980
Characterization of a Pituitary Stone
Am J Med 68:949-953, VonWestarp,C.,et al, 1980
Diagnostic Approaches to Pituitary Adenomas
Neurol 29:161-169, Drayer,B.,et al, 1979
Prolactin-Secreting Tumors & Hypogonadism in 22 Men
NEJM 299:847-852, Carter,J.N.,et al, 1978
Prolactin-secreting Pituitary Tumors
Ann Neurol 2:148, Antunes,J.L.,et al, 1977